Signal2026-04-21
ClinicalTrials.gov

[PHASE1] A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

Part of

Prostate Cancer Biomarker And Treatment Research

Open primary sourceSee the whole picture